8-KSecurities & Listing

MICROCHIP TECHNOLOGY INC 8-K Report, Unregistered Securities Sale (Feb 17, 2021)

Filed February 17, 2021For Securities:MCHPMCHPP

Summary

Microchip Technology Inc. (MCHP) announced on February 17, 2021, that it has entered into privately-negotiated exchange agreements to retire approximately $81.0 million of its 2025 Notes, $122.2 million of its 2027 Notes, and $156.0 million of its 2037 Convertible Senior Subordinated Notes. In exchange for these notes, Microchip will issue approximately 3.7 million shares of its common stock and pay approximately $359.2 million in cash. This transaction is significant as it represents a debt-for-equity and debt-for-cash swap, aimed at reducing outstanding convertible debt. The company will fund the cash portion through its existing credit facility and cash reserves. The issuance of shares is being conducted under a private placement exemption (Section 4(a)(2) of the Securities Act), targeting accredited institutional investors and qualified institutional buyers, meaning these shares are not registered with the SEC. The transaction is expected to close around February 18, 2021.

Key Highlights

  • 1Microchip is exchanging approximately $81.0M of 2025 Notes, $122.2M of 2027 Notes, and $156.0M of 2037 Notes.
  • 2The company will issue ~3.7 million shares of common stock and pay ~$359.2 million in cash for these notes.
  • 3The exchange aims to reduce Microchip's outstanding convertible debt principal.
  • 4The cash portion of the exchange will be funded by existing credit facilities and cash on hand.
  • 5Shares are being issued via a private placement under Section 4(a)(2) of the Securities Act, not through public markets.
  • 6The issuance is limited to institutional accredited investors or qualified institutional buyers.
  • 7The transaction is expected to close on or about February 18, 2021.

Frequently Asked Questions

The primary purpose is to reduce Microchip's outstanding convertible debt. By exchanging these notes for cash and newly issued shares, the company is proactively managing its capital structure and reducing its debt obligations.

No, the shares of common stock to be issued in these exchange transactions will be issued pursuant to the exemption from registration requirements afforded by Section 4(a)(2) of the Securities Act. They are being sold in a private placement to sophisticated investors, not through a public offering.

Microchip plans to fund the cash component of these exchanges through borrowings under its Amended and Restated Credit Agreement and with its existing cash and cash equivalents.

After the exchange, approximately $141.5 million of the 2025 Notes, $333.4 million of the 2027 Notes, and $122.6 million of the 2037 Notes will remain outstanding. These remaining notes will retain their original terms.